Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by Righttothetopon Jun 21, 2021 2:39pm
83 Views
Post# 33421337

RE:RE:RE:RE:RE:LABS partners with McMaster University Big Industry News:

RE:RE:RE:RE:RE:LABS partners with McMaster University Big Industry News:If an exclusive European partnership with a pharma doing north of $2billion Euros annually didn't do anything for our credibility....not sure what a scratch and sniff NR with Mac is going to do; especially in the short term.

It ain't a bad news story....but it's ain't what we need either and they need to keep their eye on the going concern ball more than developing drugs that won't see the light of day for 10+yrs, if ever noting the rigourous demands of clinical trials.

beaniw wrote: A different opinion posted on LinkedIn a few hours ago:

"Another notable credibility boost for MediPharm Labs (LABS #TSX $0.47 / MEDIF #OTCQX / MLZ #FSE) as they partner with McMaster University on #cannabis #painmanagement & #insomnia. This further elevates Medipharm near the forefront as a Cannabis #pharmaceutical company. Press release here:"

https://lnkd.in/gCRWh4a


<< Previous
Bullboard Posts
Next >>